(Q43968119)

28 November 2017

title

Gene therapy for Parkinson's disease: do we have the cure? (English)

1 reference

28 November 2017

0 references

1 reference

Alim Louis Benabid

1

1 reference

28 November 2017

publication date

1 December 2010

1 reference

28 November 2017

1 reference

28 November 2017

volume

9

1 reference

28 November 2017

issue

12

1 reference

28 November 2017

page(s)

1142-1143

1 reference

Gene delivery of AAV2-neurturin for Parkinson's disease: a double-blind, randomised, controlled trial

28 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970256-8

7 January 2021

Safety and tolerability of gene therapy with an adeno-associated virus (AAV) borne GAD gene for Parkinson's disease: an open label, phase I trial

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970256-8

7 January 2021

Subthalamic GAD gene therapy in a Parkinson's disease rat model

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970256-8

7 January 2021

Delivery of neurturin by AAV2 (CERE-120)-mediated gene transfer provides structural and functional neuroprotection and neurorestoration in MPTP-treated monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970256-8

7 January 2021

A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970256-8

7 January 2021

Gene therapy for dopamine replacement in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970256-8

7 January 2021

10.1016/S1474-4422(10)70256-8

Identifiers

DOI

1 reference

28 November 2017

1 reference